Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares

Summary by AI BETAClose X

Centessa Pharmaceuticals plc has announced a proposed underwritten public offering of American Depositary Shares, with the company offering all ADSs and granting underwriters a 30-day option to purchase up to an additional 15%. The offering is contingent on market and other conditions, and there is no certainty regarding its completion, size, or terms.

Disclaimer*

UK 100

Latest directors dealings